How does LL-37 specifically enhance wound healing?

LL-37 enhances wound healing by promoting cell migration, proliferation, and angiogenesis. It stimulates fibroblast activity and collagen synthesis, critical for tissue repair.

What makes LL-37 different from other antimicrobial peptides?

Unlike many antimicrobial peptides, LL-37 not only kills pathogens but also modulates immune responses and promotes healing, making it multifunctional.

When is the best time to administer LL-37 for optimal results?

Administering LL-37 shortly after injury or at the onset of infection maximizes its benefits; for chronic conditions, regular dosing is recommended.

Can LL-37 be combined with other compounds for enhanced effects?

Yes, combining LL-37 with other wound healing agents or antimicrobial peptides can amplify its effects, leading to better outcomes in healing and infection control.

What dosage of LL-37 is typically recommended for therapeutic use?

Typical dosages range from 0.5 to 2 mg/kg for injections, depending on the condition being treated and the route of administration.

Is LL-37 safe for long-term use?

LL-37 has shown a good safety profile in clinical studies, with no significant adverse effects reported for long-term use.

What are the potential side effects of LL-37?

Most side effects are mild, such as local irritation or redness. Serious side effects are rare, making it generally well-tolerated.

How does LL-37 interact with the immune system?

LL-37 interacts with various immune cells, enhancing their response to pathogens and regulating inflammation, which is crucial for effective immune function.

PeptideKey Peptide Database

Cathelicidin (ll-37): 47 Studies. How it Works

Explore LL-37 peptide's powerful antimicrobial & immune benefits. Discover evidence-based dosing and the latest research on PeptideKey.

This page is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.